NEOGENOMICS INC (NEO) Stock News
NASDAQ:NEO - Nasdaq - US64049M2098 - Common Stock - Currency: USD
NEO Latest News, Press Relases and Analysis
NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer
Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could worsen the already wide US fiscal deficit.
NeoGenomics to Participate in Upcoming June Investor Conferences
3 Healthcare Stocks with Mounting Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 6.4%. This drawdown was disappointing since the S&P 500 stood firm.
Mentions: PRVA
It's Not Too Late to Jump on These Under-the-Radar Momentum Plays
These three stocks may fly under the radar, but their recent price increases could appeal to investors seeking a momentum play.
NeoGenomics price target lowered to $10 from $17 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on NeoGenomics (NEO) to $10 from $17 and keeps an Equal Weight rating on the shares. The company’s Q1 miss was primarily driven by lower non-clinical revenue and lower than expected average unit price, says the analyst, who sees “more questions than answers” following the company’s quarterly report. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analys
NeoGenomics Pays Off 1.25% Convertible Senior Notes
NeoGenomics Reports First Quarter 2025 Results
Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: GSK
NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: BMY
Ask an Advisor: Should I Use My 401(k) to Pay Off My Mortgage and Add $800 to My Budget?
Is it smart to pay off my mortgage with money from my 401(k) and save $800 more per month? The mortgage balance is $60,000. – Robert Many people consider paying off their mortgage to be a "must do" before retiring. While there are benefits to this approach, there are also tradeoffs, so it's good that […] The post Ask an Advisor: Is It Smart to Pay Off My Mortgage With My 401(k) to Free Up $800 Each Month? appeared first on SmartReads by SmartAsset.
NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting
NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025
NeoGenomics Completes Acquisition of Pathline
